Baseline data will be collected following consent and will include medical history (e.g. PAH diagnosis, BMPR2 mutation and PAH medication), demographics, vital signs, urine pregnancy test, WHO class, blood tests and eligibility confirmation. Here, BMPR2 is linked to pulmonary arterial hypertension.